Chair exercised or converted 47K OVID derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Mar 23, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Mar 26, 2026
ChairOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001256153-26-000004
Added to OQROOct 7, 2026, 5:52 AM UTC Data qualityVerified: identifiers matched exactly IssuerOvid Therapeutics Inc. Reporting personJeremy M Levin RelationshipDirector, Officer Officer titleExecutive Chairman SecuritySeries A Warrant (right to buy) TableDerivative (Table II) Transaction dateMar 23, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- Each Series A Warrant became immediately exercisable pursuant to the approval of the Issuer's Stockholders on December 11, 2025.
Around the same time
Traded Apr 7 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Apr 7 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Apr 7 · filed 2 days later
Compensation award — excluded from discretionary-purchase analysis.